Navigation Links
Weizmann Researchers Developed Control Switch for Protein Activity

Our bodies could not maintain their existence without thousands of proteins performing myriad vital tasks within cells. Since malfunctioning proteins can cause disease , the study of protein structure and function can lead to the development of drugs and treatments for numerous disorders. Despite enormous research efforts led by scientists worldwide, the cellular function of numerous proteins is still unknown.

To reveal this function, scientists perform various genetic manipulations to increase or, conversely, decrease the production of a certain protein, but existing manipulations of this sort are complicated and do not fully meet the researchers needs.

Prof. Mordechai Moti Liscovitch and graduate student Oran Erster of the Weizmann Institutes Biological Regulation Department, together with Dr. Miri Eisenstein of Chemical Research Support, have recently developed a unique switch that can control the activity of any protein, raising it several-fold or stopping it almost completely. The method provides researchers with a simple and effective tool for exploring the function of unknown proteins, and in the future the new technique may find many additional uses.

The switch has a genetic component and a chemical component: Using genetic engineering, the scientists insert a short segment of amino acids into the amino acid sequence making up the protein. This segment is capable of binding strongly and selectively to a particular chemical drug, which affects the activity level of the engineered protein by increasing or reducing it. When the drug is no longer applied, or when it is removed from the system, the protein returns to its natural activity level.

As reported recently in the journal Nature Methods, the first stage of the method consists of preparing a set of genetically engineered proteins (called a library in scientific language) with the amino acid segment inserted in different places. In the second stage, the engi neered proteins are screened to identify the ones that respond to the drug in a desired manner.

The researchers have discovered that in some of the engineered proteins the drug increased the activity level, while in others this activity was reduced. Says Prof. Liscovitch: We were surprised by the effectiveness of the method it turns out that a small set of engineered proteins is needed to find the ones that respond to the drug. With their greater resources, biotechnology companies will be able to create much larger sets of engineered proteins in order to find one that best meets their needs.

The method developed by the Weizmann Institute scientists is ready for immediate use, both in basic biomedical research and in the pharmaceutical industry, in the search for proteins that can serve as targets for new drugs.

Beyond offering a potent tool that can be applied to any protein, the method has an important advantage compared with other techniques: It allows the total and precise control over the activity of an engineered protein. Such activity can be brought to a desired level or returned to its natural level, at specific locations in the body and at specific times all this by giving exact and well-timed doses of the same simple drug.

In addition, the method could be used one day in gene therapy. It may be possible to replace damaged proteins that cause severe diseases with genetically engineered proteins, and to control these proteins activity levels in a precise manner by giving appropriate doses of the drug. Another potential future application is in agricultural genetic engineering.

The method might make it possible, for example, to create genetically engineered plants in which the precise timing of fruit ripening would be controlled using a substance that increases the activity of proteins responsible for ripening. Moreover, numerous proteins are used in industrial processes, as biological sensors and in other applications. The possibility of controlling these applications strengthening or slowing the rate of protein activity in an immediate and reversible manner can be of great value.


'"/>




Related medicine news :

1. Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function
2. Researchers urge caution in using ear tube surgery
3. Researchers Scale to assess the Severity of Epilepsy in Kids
4. Researchers trick Alzheimers Enzyme
5. Researchers find new HIV hiding place
6. New Hair in 15 Days Could Now Be A Possibility Say Researchers
7. Researchers developed world’s smallest toothbrus
8. Researchers discover receptor cells that can cause epilepsy
9. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
10. Researchers reversed the process of memory loss
11. Researchers Identify Key Gene That May Help Brain Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... ... 2016 , ... New Brunswick, New Jersey: This year marks Children’s Specialized Hospital ... To commemorate the anniversary, the hospital has themed the milestone “Hats Off” and kicked ... Hospital Foundation on Saturday, May 21, at Johnson Park in Piscataway, New Jersey. ...
(Date:5/24/2016)... Bahama (PRWEB) , ... May 24, 2016 , ... Regenerative ... Such breakthroughs in adult stem cell therapy technology, protocols and patient results as have ... emerging field to become a more accessible standard of care for patients worldwide. , ...
(Date:5/24/2016)... Linda, CA (PRWEB) , ... May 24, 2016 , ... ... will house the new adult hospital and expanded Children’s Hospital. Over 3,000 people looked ... 22. , Check out the event photo slidehsow. , During the program, ...
(Date:5/24/2016)... Fla. (PRWEB) , ... May 24, 2016 , ... Boyd ... the Concealed Delivery Unit® (CDU), a groundbreaking new product for pediatric dentistry , ... Pediatric Dentistry in San Antonio, TX May 26-29. The Concealed Delivery Unit keeps dental ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... A newly ... rely heavily on their access to trusted resources, both in face-to-face interactions and online. ... Men of Color,” researchers concluded that the creative use of mobile digital devices can ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Los innovadores de COMBO[TM], ... introduce catéteres para la intervención de extremidades inferiores ... global especializada en el suministro de soluciones vasculares ... incluyendo productos para tratar la enfermedad arterial periférica. ... los dispositivos de primera entrada de la compañía ...
(Date:5/24/2016)... AMSTERDAM , May 24, 2016 Dutch ... their best practices around the world and treat patients on a ... Africa , Asia and the ... streaming with instant messaging and networking in a totally secure environment. ... Frontieres in a war zone working together with a surgeon at ...
(Date:5/23/2016)... , May 23, 2016 ... across 163 pages, profiles 12 companies and the Paclitaxel ... and figures on the industry and its players. ... is comprehensive in nature, details the current state of ... industry including definitions, classifications, applications and industry chain structure. ...
Breaking Medicine Technology: